Outcomes of a drug shortage requiring switching in patients with ulcerative colitis

BACKGROUND: Drug shortages are common yet their impact on patient care and their commercial ramifications has not been adequately researched. In Australia a shortage of balsalazide (2012-2013) necessitated substitution with alternative 5-aminosalicylate (5-ASA) formulations for ulcerative colitis (U...

Descripción completa

Detalles Bibliográficos
Autores principales: van Langenberg, Daniel R, Cheng, Richard Kai-Yuan, Garg, Mayur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156848/
https://www.ncbi.nlm.nih.gov/pubmed/32318313
http://dx.doi.org/10.4291/wjgp.v11.i2.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156848/
https://www.ncbi.nlm.nih.gov/pubmed/32318313
http://dx.doi.org/10.4291/wjgp.v11.i2.32

Ejemplares similares